Know Labs Plunges 14.47% Amid Sale, Patent Scrutiny

On June 10, 2025, Know Labs experienced a significant drop of 14.47% in pre-market trading, raising concerns among investors about the company's recent developments.

Know Labs has been under intense scrutiny due to its recent sale to Goldeneye 1995 LLC, which has sparked interest among shareholders and market analysts. The investigation by a class action firm in New York City is focused on the legality and financial implications of this transaction, adding to the uncertainty surrounding the company's future.

Additionally, Know Labs is facing scrutiny regarding its compliance with technology and design patents. The company's ERP compliance has come under the spotlight, with stakeholders and regulatory bodies closely monitoring its adherence to necessary standards and regulations. This heightened scrutiny is likely to influence the company's future operations and strategic decisions, further contributing to the volatility in its stock price.